Glisoxepide
Source: Wikipedia, the free encyclopedia.
Names | |
---|---|
Preferred IUPAC name
N-[2-(4-{[(Azepan-1-yl)carbamoyl]sulfamoyl}phenyl)ethyl]-5-methyl-1,2-oxazole-3-carboxamide | |
Identifiers | |
3D model (
JSmol ) |
|
ChEMBL | |
ChemSpider |
|
DrugBank |
|
ECHA InfoCard
|
100.042.329 |
KEGG |
|
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C20H27N5O5S | |
Molar mass | 449.52388 g/mol |
Pharmacology | |
A10BB11 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Glisoxepide (
anti-diabetic drug from the group of sulfonylureas.[1] It belongs to second-generation sulfonylureas.[2]
References
|
|
---|
VGKCsTooltip Voltage-gated potassium channels
Blockers |
|
---|---|
Activators |
|
IRKsTooltip Inwardly rectifying potassium channel
Blockers |
|
---|---|
Activators |
|
Blockers |
|
---|---|
Activators |
K2PsTooltip Tandem pore domain potassium channel
Blockers |
|
---|---|
Activators |
VGSCsTooltip Voltage-gated sodium channels
Blockers |
|
---|---|
Activators |
|
Blockers | |
---|---|
Activators |
Blockers |
---|
CaCCsTooltip Calcium-activated chloride channel
Blockers |
|
---|---|
Activators |
Blockers | |
---|---|
Activators |
Blockers |
---|
TRPs Tooltip Transient receptor potential channels |
|
---|---|
LGICs Tooltip Ligand gated ion channels |
|
gastrointestinal system is a stub. You can help Wikipedia by expanding it. |